Bright Minds Biosciences

(NASDAQ) DRUG

Current Price$88.90

Market Cap$843.85M

Since IPO (2021)+219%

5 YearN/A

1 Year+206%

1 Month+19%

Bright Minds Biosciences Financials at a Glance

Market Cap

$843.85M

Revenue (TTM)

$0.00

Net Income (TTM)

$19.84M

EPS (TTM)

$-1.94

P/E Ratio

-44.45

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$88.90

Volume

144,765

Open

$87.90

Price

$88.90

Volume

144,765

Open

$87.90

Previous Close

$88.90

Daily Range

$85.94 - $90.00

52-Week Range

$23.18 - $123.75

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$88.90

Volume

144,765

Open

$87.90

Previous Close

$88.90

Daily Range

$85.94 - $90.00

52-Week Range

$23.18 - $123.75

DRUG News

Person in a lab gazing into a microscope

Why Bright Minds Biosciences Stock Topped the Market on Monday

Eric VolkmanNov 17, 2025

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

David Jagielski, CPANov 13, 2024

DRUG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bright Minds Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ian B. McDonald

Website

www.brightmindsbio.com

Headquarters

New York City, BC V6E 4N7, CA

DRUG Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-27%

Return on Capital

-22%

Return on Assets

-22%

Earnings Yield

-2.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$843.85M

Shares Outstanding

9.79M

Volume

144.76K

Avg. Volume

151.46K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$13.94M

EBITDA

$13.86M

Operating Cash Flow

$8.69M

Capital Expenditure

$0.00

Free Cash Flow

$8.69M

Cash & ST Invst.

$82.91M

Total Debt

$125.78K

Bright Minds Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$843.85M

N/A

Market Cap/Employee

$32.46M

N/A

Employees

N/A

Net Income

$7.57M

-15349.6%

EBITDA

$6.88M

-329.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$88.94M

+54.1%

Accounts Receivable

$502.68K

+650.0%

Inventory

$0.00

N/A

Long Term Debt

$16.74K

-84.8%

Short Term Debt

$88.16K

+21.3%

Return on Assets

-21.84%

N/A

Return on Invested Capital

-21.52%

N/A

Free Cash Flow

$5.82M

-289.2%

Operating Cash Flow

$5.82M

-289.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DSGNDesign Therapeutics, Inc.

DSGNDesign Therapeutics, Inc.$14.55+8.50%

LBRXLB Pharmaceuticals Inc Common Stock

LBRXLB Pharmaceuticals Inc Common Stock$32.00-2.68%

ANNXAnnexon, Inc.

ANNXAnnexon, Inc.$5.70-0.35%

IMABI-Mab

IMABI-Mab$2.88-0.69%

AURAAura Biosciences, Inc.

AURAAura Biosciences, Inc.$8.29-6.85%

ENGNenGene Holdings Inc.

ENGNenGene Holdings Inc.$8.85+12.17%

DMACDiaMedica Therapeutics Inc.

DMACDiaMedica Therapeutics Inc.$6.52+4.32%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14-0.12%

CPNGCoupang

CPNGCoupang$17.89-0.14%

SNAPSnap

SNAPSnap$6.11+0.33%

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.57+0.06%

JOBYJoby Aviation

JOBYJoby Aviation$10.52+0.21%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.59-0.06%

Questions About DRUG

What is the current price of Bright Minds Biosciences?

Bright Minds Biosciences is trading at $88.90 per share.

What is the 52-week range for Bright Minds Biosciences?

Over the past 52 weeks, Bright Minds Biosciences has traded between $23.18 and $123.75.

How much debt does Bright Minds Biosciences have?

As of the most recent reporting period, Bright Minds Biosciences reported total debt of $76,527.448.

How much cash does Bright Minds Biosciences have on hand?

Bright Minds Biosciences reported $64.84M in cash and cash equivalents in its most recent financial results.

What is Bright Minds Biosciences’s dividend yield?

Bright Minds Biosciences does not currently have a dividend yield.

Bright Minds Biosciences

Bright Minds Biosciences Financials at a Glance

DRUG News

Why Bright Minds Biosciences Stock Topped the Market on Monday

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

DRUG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bright Minds Biosciences

DRUG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bright Minds Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DRUG

What is the current price of Bright Minds Biosciences?

What is the 52-week range for Bright Minds Biosciences?

How much debt does Bright Minds Biosciences have?

How much cash does Bright Minds Biosciences have on hand?

What is Bright Minds Biosciences’s dividend yield?

Premium Investing Services